Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents
Lindsey E. Roeker(Memorial Sloan Kettering Cancer Center), Anthony R. Mato(Memorial Sloan Kettering Cancer Center), Jennifer R. Brown(Dana-Farber Cancer Institute), Catherine C. Coombs(Memorial Sloan Kettering Cancer Center), Harriet S. Walter(Leicester Royal Infirmary), Craig S. Sauter(Memorial Sloan Kettering Cancer Center), Mark B. Geyer(Memorial Sloan Kettering Cancer Center), Danielle M. Brander(Duke University), Arvind Arumainathan(Clatterbridge Cancer Centre NHS Foundation Trust), Haesook T. Kim(Dana-Farber Cancer Institute), Toby A. Eyre(Oxford University Hospitals NHS Trust), Kim Orchard(University of Namur), Steven T. Manchini(Dana-Farber Cancer Institute), Andrew D. Zelenetz(Memorial Sloan Kettering Cancer Center), Andrea Sitlinger(Duke Medical Center), Matthew S. Davids(Dana-Farber Cancer Institute), Sergio Giralt(Memorial Sloan Kettering Cancer Center), Miguel‐Angel Perales(Memorial Sloan Kettering Cancer Center), Peter Dreger(Heidelberg University), Timothy Voorhees(University of North Carolina at Chapel Hill), Nirav N. Shah(Medical College of Wisconsin), Gemlyn George(Medical College of Wisconsin), Oscar Lahoud(Memorial Sloan Kettering Cancer Center), Jae H. Park(Memorial Sloan Kettering Cancer Center), Alan P Skarbnik(Novant Health)
Cited by 86
Related Papers
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k